Skip to content

Safety and effectiveness of Nigella sativa in enhancing breast milk secretion.

Safety and Efficacy of Shuneez (Nigella sativa) as galactogogue: A Randomized Placebo Controlled Clinical Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/11/038329
Enrollment
100
Registered
2021-11-29
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O94-O9A- Other obstetric conditions, not elsewhere classified

Interventions

Intervention1: CLINICAL TRIAL: SAFETY AND EFFICACY OF NIGELLA SATIVA AS GALACTOGOGUE:A RANDOMIZED PLACEBO CONTROLLED CLINICAL STUDY Intervention2: NIL: NIL Intervention3: NIL: NIL Intervention4: NIGEL

Sponsors

DEPARTMENT OF AMRAZ E NISWAN WA ATFAL AJMAL KHAN TIBBIYA COLLEGE AMU ALIGARH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: PATIENTS HAVING INFANTS OF 0-1 MONTH OF AGE WITH COMPLAINTS OF INSUFFICIENT BREAST MILK SECRETION WITH POOR ANTHROPOMETRIC MEASURES OF HER CHILD(WEIGHT HEIGHT HEAD CIRCUMFRENCE)

Exclusion criteria

Exclusion criteria: PATIENTS LESS THAN 21 AND MORE THAN 35 YEARS OF AGE PATIENTS HAVING CHILD MORE THAN ONE MONTH OF AGE PATIENTS WITH IMPROPER POSITIONING AND LATCHING WHILE BREAST FEEDING THEIR CHILDREN PRESENCE OF ANY SYSTEMIC ILLNESS IN PATIENT OR IN HER CHILD PATIENT WHO DELIVERS PREMATURE SGA OR LGA BABY PATIENTS WHO DO NOT WILL TO BE THE PART OF STUDY

Design outcomes

Primary

MeasureTime frame
INCREASE IN BREAST MILK SECRETION AS INFORMED BY PATIENT NUMBER OF TIMES BABY MICTURATES IN 24 HOURS NUMBER OF HOURS BABY SLEEPS AFTER EVERY FEEDTimepoint: BASELINE 1 WEEK 2 WEEKS 3 WEEKS 4 WEEKS

Secondary

MeasureTime frame
RISE IN SERUM PROLACTIN LEVEL IMPROVEMENT IN ANTHROPOMETRIC MEASURES OF THE CHILDTimepoint: BASELINE 1 WEEK 2 WEEKS 3 WEEKS 4 WEEKS

Countries

India

Contacts

Public ContactSAMREEN KHAN

DEPARTMENT OF AMRAZ-E-NISWAN WA ATFAL,AJMAL KHAN TIBBIYA COLLEGE AND HOSPITAL,AMU,ALIGARH

drmanasshamsi@gmail.com9897407149

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026